160 related articles for article (PubMed ID: 37830789)
1. Risk factors and clinical characteristics of acute and chronic cutaneous graft-versus-host disease in pediatric patients undergoing hematopoietic stem cell transplantation.
González-Cruz C; Repiso T; Ferrándiz-Pulido C; Navarro A; García-Patos V
Pediatr Dermatol; 2023; 40(6):1077-1080. PubMed ID: 37830789
[TBL] [Abstract][Full Text] [Related]
2. Chronic cutaneous graft-versus-host disease in children: A report of 14 patients from a tertiary care pediatric dermatology clinic.
Nanda A; Husain MAA; Al-Herz W; Almekaimi A; Al-Sabah H; Al-Otaibi M
Pediatr Dermatol; 2018 May; 35(3):343-353. PubMed ID: 29536565
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal tract and liver graft-versus-host disease in pediatric patients with hematopoietic progenitor cell transplantation at a tertiary care center in Mexico.
Jaramillo-Esparza CM; Consuelo-Sánchez A; Acosta-Rodríguez-Bueno CP; Ramón-García G; Sadowinski-Pine SW; Escobar-Sánchez MA; Castorena-Villa I; Gaytán-Morales F; Vázquez-Frias R
Rev Gastroenterol Mex (Engl Ed); 2018; 83(4):385-392. PubMed ID: 29486973
[TBL] [Abstract][Full Text] [Related]
4. Pediatric Cutaneous Graft Versus Host Disease: A Review.
Shi CR; Huang JT; Nambudiri VE
Curr Pediatr Rev; 2017; 13(2):100-110. PubMed ID: 28641548
[TBL] [Abstract][Full Text] [Related]
5. Acute graft versus host disease in hematopoietic stem cell alotransplant recipients.
Krstevska S; Genadieva-Stavric S; Pivkova A; Stojanovski Z; Georgievski B; Balkanov T
Med Arh; 2011; 65(5):260-4. PubMed ID: 22073847
[TBL] [Abstract][Full Text] [Related]
6. Association of recipient and donor interleukin 6 polymorphisms 174 and 597 with outcome after allogeneic hematopoietic stem cell transplantation in children.
Wetzel L; Wittig S; Gruhn B
J Cancer Res Clin Oncol; 2022 Jan; 148(1):255-265. PubMed ID: 34120222
[TBL] [Abstract][Full Text] [Related]
7. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
[TBL] [Abstract][Full Text] [Related]
8. The changing face of graft-versus-host disease.
Schaffer JV
Semin Cutan Med Surg; 2006 Dec; 25(4):190-200. PubMed ID: 17174839
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous graft-versus-host disease after hematopoietic stem cell transplant - a review.
Villarreal CD; Alanis JC; Pérez JC; Candiani JO
An Bras Dermatol; 2016; 91(3):336-43. PubMed ID: 27438202
[TBL] [Abstract][Full Text] [Related]
10. Impact of graft-versus-host disease on the clinical outcome of allogeneic hematopoietic stem cell transplantation for non-malignant diseases.
Umeda K; Imai K; Yanagimachi M; Yabe H; Kobayashi M; Takahashi Y; Kajiwara M; Yoshida N; Cho Y; Inoue M; Hashii Y; Atsuta Y; Morio T;
Int J Hematol; 2020 Jun; 111(6):869-876. PubMed ID: 32052319
[TBL] [Abstract][Full Text] [Related]
11. Patterns of Genital Examination and Vulvovaginal Graft-Versus-Host Disease in a Pediatric Post-Hematopoietic Stem Cell Transplant Population.
Allen SM; Liang CS; Chesnokova AE; Childress KJ; Pascoe KF; Dietrich JE
J Pediatr Adolesc Gynecol; 2020 Dec; 33(6):658-666. PubMed ID: 32781233
[TBL] [Abstract][Full Text] [Related]
12. Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants.
Freudenberger TD; Madtes DK; Curtis JR; Cummings P; Storer BE; Hackman RC
Blood; 2003 Nov; 102(10):3822-8. PubMed ID: 12869516
[TBL] [Abstract][Full Text] [Related]
13. Triple-Drug Graft-versus-Host Disease Prophylaxis after HLA-Matched Unrelated Donor Nonmyeloablative Allogenic Hematopoietic Stem Cell Transplantation.
Wegener A; Andersen NS; Friis LS; Petersen SL; Schjødt I; Kornblit B; Sengeløv H; Gjærde LK
Transplant Cell Ther; 2023 Sep; 29(9):575.e1-575.e6. PubMed ID: 37301257
[TBL] [Abstract][Full Text] [Related]
14. Chronic graft-versus-host disease and late effects after hematopoietic stem cell transplantation.
Sanders JE
Int J Hematol; 2002 Aug; 76 Suppl 2():15-28. PubMed ID: 12430895
[TBL] [Abstract][Full Text] [Related]
15. Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.
Theurich S; Fischmann H; Shimabukuro-Vornhagen A; Chemnitz JM; Holtick U; Scheid C; Skoetz N; von Bergwelt-Baildon M
Cochrane Database Syst Rev; 2012 Sep; (9):CD009159. PubMed ID: 22972135
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
Fisher SA; Cutler A; Doree C; Brunskill SJ; Stanworth SJ; Navarrete C; Girdlestone J
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009768. PubMed ID: 30697701
[TBL] [Abstract][Full Text] [Related]
17. Early reconstitution of lymphocytes after allogenic hematopoietic stem cell transplantation affects chronic graft-versus-host disease.
Yanagi M; Kobayashi R; Matsushima S; Hori D; Kodama K; Suzuki D; Kobayashi K
Pediatr Int; 2022 Jan; 64(1):e15222. PubMed ID: 35790056
[TBL] [Abstract][Full Text] [Related]
18. Impact of skin biopsy on the management of acute graft-versus-host disease in a pediatric population.
Haimes H; Morley KW; Song H; Okhovat JP; Schmidt B; Huang JT
Pediatr Dermatol; 2019 Jul; 36(4):455-459. PubMed ID: 31016777
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
Holtick U; Albrecht M; Chemnitz JM; Theurich S; Skoetz N; Scheid C; von Bergwelt-Baildon M
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010189. PubMed ID: 24748537
[TBL] [Abstract][Full Text] [Related]
20. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
